NeuroSense Therapeutics Ltd.

Pharmaceutical company · Herzliya, Tel Aviv, Israel · Nasdaq: NRSN

NeuroSense Therapeutics Ltd. is a pharmaceutical company headquartered in Herzliya, Tel Aviv, Israel. Its shares trade on Nasdaq under the ticker NRSN. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

NeuroSense Therapeutics at a glance

Typepharmaceutical company

HeadquartersHerzliya, Tel Aviv, Israel

Stock listingNasdaq: NRSN

SEC industryPharmaceutical Preparations

SEC CIK1875091

What does NeuroSense Therapeutics do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $5 million sold (2024).

Frequently asked questions about NeuroSense Therapeutics

Where is NeuroSense Therapeutics headquartered?

NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Tel Aviv, Israel.

What does NeuroSense Therapeutics do?

NeuroSense Therapeutics Ltd. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is NeuroSense Therapeutics a public company?

Yes. NeuroSense Therapeutics Ltd. trades on Nasdaq under the ticker NRSN.

Similar companies

UroGen Pharma Ltd.Ra'anana, Central District, Israel
MediWound Ltd.Yavné, Central District, Israel
RedHill Biopharma Ltd.Tel Aviv, Israel
Chemomab Therapeutics Ltd.Tel Aviv, Israel
Nasus Pharma LtdTel Aviv, Israel
Can-Fite BioPharma Ltd.Ramat Gan, Tel Aviv, Israel
BioLineRx Ltd.Modi‘in Makkabbim Re‘ut, Central District, Israel

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.